Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Hepatocellular 8Liver Neoplasms 7Colorectal Neoplasms 3Unresectable Pancreatic Cancer 2Stomach Neoplasms 2Neoplasm Metastasis 2Locally Advanced Pancreatic Cancer 2Cholangiocarcinoma 2Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma Resectable 1Pancreatic Adenocarcinoma Locally Advanced 1Liver Metastasis Colon Cancer 1Liver Diseases 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Liver Metastases 1Bile Duct Neoplasms 1Advanced Gastric Cancer 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Photochemotherapy 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Radiofrequency Ablation 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Drug Therapy 3Dihematoporphyrin Ether 3Dexamethasone 3Cholangiopancreatography, Endoscopic Retrograde 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Electroporation × Gastrointestinal × Clear all
NCT04404647 2021-03-26

Irreversible Electroporation of Unresectable Liver Tumors

Aalborg University Hospital

Phase NA Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡